Adjuvant Cesium‐131 Brachytherapy for Patients Intolerant of External Beam Radiation Therapy-Reference-Cited by-同舟云学术

Adjuvant Cesium‐131 Brachytherapy for Patients Intolerant of External Beam Radiation Therapy

Published:2021-03-17 Issue:8 Volume:131 Page:
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Sagheer S. Hamad¹^ORCID,Bornstein Jonathan¹^ORCID,Bar‐Ad Vochita²,Cheng Michael³,Cummins Andi⁴,Cognetti David M.¹,Curry Joseph¹,Yao Min⁴,Lavertu Pierre⁴^ORCID,Kutler David I.³,Zender Chad⁵^ORCID,Luginbuhl Adam J.¹

Affiliation:

1. Department of Otolaryngology Thomas Jefferson University Philadelphia Pennsylvania U.S.A.

2. Department of Radiation Oncology Thomas Jefferson University Philadelphia Pennsylvania U.S.A.

3. Department of Otolaryngology New York‐Presbyterian Weill Cornell Medical Center New York New York U.S.A.

4. Department of Radiation Oncology Case Western Reserve School of Medicine Cleveland Ohio U.S.A.

5. Department of Otolaryngology University of Cincinnati Cincinnati Ohio U.S.A.

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.29406

Reference5 articles.

1. Single institution implementation of permanent 131Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma

2. Cesium-131 permanent seed brachytherapy: Dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff

3. Carotid dosimetry after re-irradiation with 131Cs permanent implant brachytherapy in recurrent, resected head and neck cancer

4. Cesium‐131 interstitial brachytherapy for recurrent malignancies of Skull Base;Savard C;J Neurol Surg Rep,2019

5. Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer;Frontiers in Oncology;2021-11-26